Studies have shown that loss of function of tyrosine protein kinase in EGFR pathway or abnormal activity or cell localization of key factors in the pathway can lead to the occurrence of tumor, diabetes, and immune deficiency [37–39]. This evidence concerns the gene EGFR and neoplasm.